SOPHiA GENETICS (SOPH) Research & Development (2020 - 2025)
Historic Research & Development for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$8.1 million.
- SOPHiA GENETICS's Research & Development fell 245.11% to -$8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.8 million, marking a year-over-year increase of 46.02%. This contributed to the annual value of -$34.4 million for FY2024, which is 704.1% up from last year.
- Per SOPHiA GENETICS's latest filing, its Research & Development stood at -$8.1 million for Q3 2025, which was down 245.11% from -$8.5 million recorded in Q2 2025.
- In the past 5 years, SOPHiA GENETICS's Research & Development registered a high of -$6.2 million during Q1 2021, and its lowest value of -$10.1 million during Q3 2022.
- In the last 5 years, SOPHiA GENETICS's Research & Development had a median value of -$8.9 million in 2023 and averaged -$8.4 million.
- Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 9984.75% in 2021, then tumbled by 5331.72% in 2022.
- Over the past 5 years, SOPHiA GENETICS's Research & Development (Quarter) stood at -$6.4 million in 2021, then dropped by 6.79% to -$6.8 million in 2022, then tumbled by 43.73% to -$9.8 million in 2023, then rose by 6.31% to -$9.1 million in 2024, then rose by 11.77% to -$8.1 million in 2025.
- Its Research & Development stands at -$8.1 million for Q3 2025, versus -$8.5 million for Q2 2025 and -$9.1 million for Q1 2025.